Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beneficial gut microbiota" refers to populations of bacteria, archaea, fungi, and viruses in the gastrointestinal tract that support host health by performing functions such as nutrient metabolism, maintaining the gut barrier, modulating immune responses, excluding pathogens, and producing vital metabolites. This community is not a single entity but a diverse, dynamic ecosystem that varies between individuals and throughout life. Changes or disruption in its composition (dysbiosis) have been implicated in the pathogenesis of a wide range of diseases, including inflammatory, metabolic, neurodegenerative, and neoplastic disorders. Therapeutic strategies are being investigated to restore or support beneficial gut microbiota through approaches such as diet, probiotics, prebiotics, synbiotics, targeted antibiotics, and fecal microbiota transplantation[1][2][6][7][9]. The term does not describe a single, druggable target but rather a class of mixed organisms collectively essential for healthy human physiology.
Restoration or modulation of microbial composition (through probiotics, prebiotics, synbiotics, fecal microbiota transplantation); Modulation of microbial metabolism to affect drug activation, immune response, or nutrient production; Inhibition of specific bacterial enzymes to improve drug efficacy/safety (e.g., β-glucuronidase inhibitors)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on beneficial gut microbiota.